StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by sleepydog1on Mar 29, 2019 8:45am

106 Views

Post# 29552870

RE:RE:RE:RE:RE:RE:The future is now for GEN

Doesn't hurt that GEN has 10 times the potential of % returns then any other company on the senior circuit .... people see GEN up near the top in volume leaders everyday and if they want to make huge returns I don't see anything else on the senior exchange that even remotely comes close ... SD1

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale